At a glance
- Originator Eli Lilly and Company
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 20 Oct 1999 New profile
- 20 Oct 1999 Preclinical development for Influenza virus infections in USA (Unknown route)